Logan Zhang

649 total citations
5 papers, 123 citations indexed

About

Logan Zhang is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Logan Zhang has authored 5 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Immunology and 2 papers in Biomedical Engineering. Recurrent topics in Logan Zhang's work include CAR-T cell therapy research (3 papers), Nanowire Synthesis and Applications (2 papers) and Neuroblastoma Research and Treatments (1 paper). Logan Zhang is often cited by papers focused on CAR-T cell therapy research (3 papers), Nanowire Synthesis and Applications (2 papers) and Neuroblastoma Research and Treatments (1 paper). Logan Zhang collaborates with scholars based in United States, Switzerland and China. Logan Zhang's co-authors include Donald M. O’Rourke, Zev A. Binder, Laura Roccograndi, Nadia Dahmane, Guo‐li Ming, Radhika Thokala, Hongjun Song, Michael C. Milone, Zhuo Zhang and Mohamed Bentires‐Alj and has published in prestigious journals such as Molecular Therapy, Frontiers in Oncology and Journal of Neuro-Oncology.

In The Last Decade

Logan Zhang

5 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Logan Zhang United States	5	63	35	29	28	26	5	123
Esther Hian Li Chan Singapore	6	66 1.0×	27 0.8×	17 0.6×	28 1.0×	8 0.3×	17	106
Harry Miao United States	9	104 1.7×	28 0.8×	16 0.6×	16 0.6×	10 0.4×	33	149
Guido Ghilardi United States	6	36 0.6×	47 1.3×	27 0.9×	6 0.2×	5 0.2×	19	95
Omar Castañeda Puglianini United States	9	122 1.9×	88 2.5×	21 0.7×	25 0.9×	17 0.7×	30	194
Anastasia I. Kousa United States	6	37 0.6×	138 3.9×	5 0.2×	28 1.0×	9 0.3×	11	196
R Facchini United Kingdom	4	31 0.5×	31 0.9×	23 0.8×	45 1.6×	7 0.3×	5	106
Séverine Augier France	4	50 0.8×	38 1.1×	12 0.4×	36 1.3×	7 0.3×	5	138
Virginie Persoons France	5	38 0.6×	63 1.8×	31 1.1×	50 1.8×	11 0.4×	6	146
Christine Ann Pittman Ballard United States	2	10 0.2×	27 0.8×	59 2.0×	9 0.3×	16 0.6×	5	115

Countries citing papers authored by Logan Zhang

Since Specialization

Citations

This map shows the geographic impact of Logan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Logan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Logan Zhang more than expected).

Fields of papers citing papers by Logan Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Logan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Logan Zhang. The network helps show where Logan Zhang may publish in the future.

Co-authorship network of co-authors of Logan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Logan Zhang. A scholar is included among the top collaborators of Logan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Logan Zhang. Logan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Li, Nannan, Jesse L. Rodriguez, Yibo Yin, et al.. (2024). Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma. Molecular Therapy. 32(10). 3522–3538. 22 indexed citations

2.

Wang, Xin, Benjamin Philipson, Qian Zhang, et al.. (2022). The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity. Molecular Therapy — Oncolytics. 27. 288–304. 23 indexed citations

3.

Thokala, Radhika, Zev A. Binder, Yibo Yin, et al.. (2021). High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms. Frontiers in Oncology. 11. 664236–664236. 22 indexed citations

4.

Viaene, Angela N., Bo Zhang, María Martínez-Lage, et al.. (2019). Transcriptome signatures associated with meningioma progression. Acta Neuropathologica Communications. 7(1). 67–67. 26 indexed citations

5.

Roccograndi, Laura, Zev A. Binder, Logan Zhang, et al.. (2017). SHP2 regulates proliferation and tumorigenicity of glioma stem cells. Journal of Neuro-Oncology. 135(3). 487–496. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact